CoChat

Recent insights into factors affecting remnant lipoprotein uptake

Williams, Kevin Jon, Chen, Keyang · 2010 · Current Opinion in Lipidology

The DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index.

Abstract

PURPOSE OF REVIEW: Remnant lipoproteins that persist in the bloodstream after each meal have become increasingly important contributors to atherosclerotic vascular disease, owing to the spread of overnutrition, underexertion, obesity, insulin resistance, and type 2 diabetes. Here, we review recent work that clarified long-standing controversies over the molecular mediators of remnant clearance by the liver, as well as their dysregulation - but possible correction - during alterations in caloric balance. RECENT FINDINGS: Two endocytic receptors, the syndecan-1 heparan sulfate proteoglycan (HSPG) and the LDL receptor, plus one docking receptor, SR-BI, significantly contribute to normal hepatic remnant catabolism. Compelling evidence exists for dysfunction of the syndecan-1 HSPG in diabetic states. The major molecular defect identified so far in poorly controlled type 1 diabetes is impaired hepatic HSPG assembly. In contrast, the primary defect in hepatic HSPGs in type 2 diabetes appears to arise from accelerated de-sulfation, owing to the induction of a sulfatase. Moreover, short-term caloric restriction restores hepatic expression of this sulfatase towards normal. SUMMARY: Correct identification of hepatic remnant receptors has finally allowed investigations of their molecular dysregulation in diabetes and related conditions. New work points to novel therapeutic targets to correct postprandial dyslipoproteinemia and its consequent arterial damage.

Overview

Integrity signals

Registry

Crossref · 10.1097/mol.0b013e328338cabc

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 134 references

Research works printed but not linked: 8

  1. Parhofer, 2000, J Clin Endocrinol Metab, 85, 4224
  2. Williams, 2001, Methods Mol Biol, 171, 457
  3. Stanford, 2009, J Clin Invest, 119, 3236
  4. Han, 2009, J Clin Invest, 119, 1029
  5. Murao, 2007, Am J Physiol, 294, E78
  6. Ybarra, 2001, Diabetes Metab, 27, 701
  7. Mooradian, 2009, Nat Clin Pract Endocrinol Metab, 5, 150
  8. Liu, 2004, Arterioscler Thromb Vasc Biol, 24, E

Cited by

See all 96

Metadata

Authors
Williams, K. J., & Chen, K.
Affiliations
Temple University (US)
Corresponding author
Williams, Kevin Jon
Venue
Current Opinion in Lipidology
Published
2010-06
Volume
21
Issue
3
Pages
218-228
ISSN
0957-9672 (ISSN-L)
OpenAlex
W1966190991
Cited by
91
References
135
Citations by year
2025: 4 · 2024: 2 · 2023: 2 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 12 · 2015: 10 · 2014: 4 · 2013: 11 · 2012: 12
FWCI
1.92
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Lipidology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (HL 38956, R01HL094277, R01HL073898, HL73898, HL94277)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK043396)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
remnant lipoproteins, syndecan-1, heparan sulfate proteoglycans, LDL receptor, scavenger receptor class B type I, type 2 diabetes, type 1 diabetes, sulfatase, caloric restriction, atherosclerosis, energy balance
MeSH terms
Amino Acid Sequence, Animals, Biological Transport, Diabetes Mellitus, Humans, Lipoproteins, Liver, Molecular Sequence Data, Receptors, LDL, Postprandial Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent insights into factors affecting remnant lipoprotein uptake. https://app.cochat.ai/papers/10.1097/mol.0b013e328338cabc
The paper
Williams, K. J., & Chen, K. (2010). Recent insights into factors affecting remnant lipoprotein uptake. Current Opinion in Lipidology. https://doi.org/10.1097/mol.0b013e328338cabc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.